Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris
- 31 October 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (4), 903-912
- https://doi.org/10.1016/0002-9149(82)91252-8
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.Circulation, 1982
- Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.Circulation, 1982
- The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol.Circulation, 1982
- Exacerbation of vasotonic angina pectoris by propranolol.Circulation, 1982
- A Controlled Trial of Verapamil for Prinzmetal's Variant AnginaNew England Journal of Medicine, 1981
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation, 1979
- Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.Circulation, 1978
- Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscleCardiovascular Research, 1972